PRL and neoplasm: In particular, in the transition age, a genetic background due to germline mutations in the Aryl hydrocarbon receptor Interacting Protein (AIP) or in the MEN1 genes should be considered, especially in GH- and/or PRL-secreting tumours [31, 42, 43], although such information was not uniformly sought in this cohort.